These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3063916)

  • 1. Modification of the pattern of infection and evolution of cardiopathy in experimental Chagas' disease after treatment with immunosuppressive and trypanocidal drugs.
    Cabeza Meckert PM; Chambó JG; Laguens RP
    Medicina (B Aires); 1988; 48(1):7-11. PubMed ID: 3063916
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of antibody dependent cytotoxicity to Trypanosoma cruzi in chronic chagasic mice after treatment with nifurtimox.
    Chambó JG; Cabeza Meckert PM; Laguens RP
    Medicina (B Aires); 1988; 48(1):49-53. PubMed ID: 3146009
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nifurtimox, a bright future for treatment of Chagas disease].
    Wolf A; Boulliat C; Coillot C; Rouault M; Gaillard K; Beranger C; Oliver M
    Med Trop (Mars); 2011 Apr; 71(2):131-3. PubMed ID: 21695868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of Chagas' disease].
    Apt W
    Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147
    [No Abstract]   [Full Text] [Related]  

  • 5. [Etiological treatment of Chagas' disease].
    Rassi A
    Arq Bras Cardiol; 1982 Apr; 38(4):277-81. PubMed ID: 6820273
    [No Abstract]   [Full Text] [Related]  

  • 6. Heart damage comparing three strains of mice chronically infected with Trypanosoma cruzi.
    Morales MC; Cardoni RL; Rimoldi MT; Esteva M; Milei J
    Medicina (B Aires); 1987; 47(5):493-9. PubMed ID: 3333075
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined treatment with a nitrofuranic and a corticoid in experimental Chagas' disease in the dog.
    Andrade SG; Andrade ZA; Sadigursky M
    Am J Trop Med Hyg; 1980 Sep; 29(5):766-73. PubMed ID: 6776831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characterization of Trypanosoma cruzi strains isolated from patients with heart transplantation].
    Lahura PN; Matsubara L; Amato Neto V; Okumura M; Bocchi EA
    Rev Hosp Clin Fac Med Sao Paulo; 1995; 50(2):97-100. PubMed ID: 7569603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice.
    Lo Presti MS; Rivarola HW; Bustamante JM; Fernández AR; Enders JE; Fretes R; Gea S; Paglini-Oliva PA
    Int J Antimicrob Agents; 2004 Jun; 23(6):634-6. PubMed ID: 15194137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Etiologic therapy of Chagas' disease].
    Boainain E; Rassi A
    Arq Bras Cardiol; 1979 Jun; 32(6):395-9. PubMed ID: 116629
    [No Abstract]   [Full Text] [Related]  

  • 11. Indeterminate Chagas' disease: Trypanosoma cruzi strain and re-infection are factors involved in the progression of cardiopathy.
    Bustamante JM; Rivarola HW; Fernández AR; Enders JE; Fretes R; Palma JA; Paglini-Oliva PA
    Clin Sci (Lond); 2003 Apr; 104(4):415-20. PubMed ID: 12653687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens].
    Moretti E; Cervetta L; Basso B; Castro I; Santamarina N
    Bol Chil Parasitol; 1998; 53(1-2):3-9. PubMed ID: 9830716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies.
    Cabrera E; Murguiondo MG; Arias MG; Arredondo C; Pintos C; Aguirre G; Fernández M; Basmadjián Y; Rosa R; Pacheco JP; Raymondo S; Di Maio R; González M; Cerecetto H
    Eur J Med Chem; 2009 Oct; 44(10):3909-14. PubMed ID: 19446929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in resistance to reinfection with low and high inocula of Trypanosoma cruzi in chagasic mice treated with nifurtimox and relation to immune response.
    Cabeza Meckert P; Chambó JG; Laguens RP
    Antimicrob Agents Chemother; 1988 Feb; 32(2):241-5. PubMed ID: 3129986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated immunity in Chagas' disease: Alterations induced by treatment with a trypanocidal drug (nifurtimox).
    Lelchuk R; Cardoni RL; Fuks AS
    Clin Exp Immunol; 1977 Dec; 30(3):434-8. PubMed ID: 414867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Exoantigens of Trypanosoma cruzi. Epitopes reactive against immunoglobulins of patients with Chagas' disease].
    Gruppi A; Moretti ER; Basso B; Vottero-Cima E
    Medicina (B Aires); 1988; 48(2):161-6. PubMed ID: 3148093
    [No Abstract]   [Full Text] [Related]  

  • 17. Heart transplantation for Chagas' cardiomyopathy.
    Blanche C; Aleksic I; Takkenberg JJ; Czer LS; Fishbein MC; Trento A
    Ann Thorac Surg; 1995 Nov; 60(5):1406-8; discussion 1408-9. PubMed ID: 8526639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens.
    Pontes-de-Carvalho L; Santana CC; Soares MB; Oliveira GG; Cunha-Neto E; Ribeiro-dos-Santos R
    J Autoimmun; 2002 Mar; 18(2):131-8. PubMed ID: 11908945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
    Bocchi EA; Higuchi ML; Vieira ML; Stolf N; Bellotti G; Fiorelli A; Uip D; Jatene A; Pileggi F
    J Heart Lung Transplant; 1998 Apr; 17(4):399-405. PubMed ID: 9588585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the efficacy of nifurtimox in chronic human chagasic infection by using xenodiagnosis (author's transl)].
    Cerisola JA; Neves da Silva N; Prata A; Schenone H; Rohwedder R
    Bol Chil Parasitol; 1977; 32(3-4):51-62. PubMed ID: 416834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.